首站-论文投稿智能助手
典型文献
Knowledge about,attitude and acceptance towards,and predictors of intention to receive the COVID-19 vaccine among cancer patients in Eastern China:A cross-sectional survey
文献摘要:
Objective:The coronavirus disease 2019 (COVID-19) pandemic has had a serious impact on health all over the world.Cancer patient,whose immunity is often compromised,faces a huge challenge.Currently,some COVID-19 vaccines are being developed and applied on general population;however,whether cancer patients should take COVID-19 vaccine remains unknown.Our study aimed to explore the knowledge,attitude,acceptance,and predictors of intention to receive the COVID-19 vaccine among cancer patients in Eastern China.Methods:A cross-sectional study was conducted in Eastern China from June 17th to September 3rd,2021.Patients were selected using a convenience sampling method.A self-report questionnaire was developed to assess knowledge about the COVID-19 vaccine,attitude towards the vaccine and acceptance of the vac-cine;following a review of similar studies previously published in the scientific literature,multivariate logistic regression analysis was used to determine the predictors associated with COVID-19 vaccine acceptance.Results:A total of 2158 cancer patients were enrolled in this study.The rate of vaccine hesitancy was 24.05% (519/2158);further,among the participants of vaccine acceptance,767 had taken COVID-19 vac-cine (35.54%),and 872 were willing to get vaccinated (40.01%).A total of 24 variables including demo-graphic characteristics,clinical status of cancer,impact of COVID-19 pandemic on study participants,patients' knowledge about the COVID-19 vaccine,and attitude towards the vaccine,had significant dif-ferences between the "vaccine hesitancy" population and "vaccine acceptance" population.Multivariate logistic regression analysis indicated that parameters including alcohol consumption (odds ratio[OR]=1.849;95% confidence interval[CI]:1.375-2.488;P-reference[P-Ref]< 0.001 vs non-drinkers),income impacted by COVID-19 pandemic (OR =1.930,2.037 and 2.688 for mild,moderate,and severe impact,respectively;all P-Ref < 0.01 vs no impact),knowledge of how the vaccine was devel-oped (OR =1.616;95% CI:1.126-2.318;P-Ref =0.009 vs unknown),believing in the safety of the vaccine(OR =1.502;95% CI:1.024-2.203;P-Ref =0.038 vs denying the safety of vaccine),willingness to pay for the vaccine (OR =3.042;95% CI:2.376-3.894;P-Ref < 0.001 vs unwilling),and willingness to recommend families and friends to get vaccinated (OR =2.744;95% CI:1.759-4.280;P-Ref < 0.001 vs do not recom-mend) were contributors to vaccine acceptance.While such as being retired (OR =0.586;95% CI:0.438-0.784;P-Ref < 0.001 vs unemployed),undergoing multiple therapies of cancer (OR =0.408;95% CI:0.221-0.753;P-Ref =0.004 vs no ongoing treatment),and worrying that the vaccine might deteriorate the prog-nosis of cancer (OR =0.393;95% CI:0.307-0.504;P-Ref < 0.001 vs might not) were contributors to vaccine hesitancy.Conclusion: This study provided preliminary estimates of the rates of vaccine acceptance and vaccine hesitancy among cancer patients in Eastern China. The intention to receive the COVID-19 vaccine was impacted by factors such as patient occupation, alcohol consumption, and some parts of knowledge about and attitude towards COVID-19 vaccine. It is recommended to develop individualized vaccination plans that meet the healthcare needs of cancer patients.
文献关键词:
作者姓名:
Jing Hong;Xiao-wan Xu;Jing Yang;Jing Zheng;Shu-mei Dai;Ju Zhou;Qing-mei Zhang;Yi Ruan;Chang-quan Ling
作者机构:
School of Traditional Chinese Medicine,Naval Medical University,Shanghai 200433,China;Department of Integrative Oncology,Changhai Hospital,Naval Medical University,Shanghai 200433,China;Department of Oncology,The First Affiliated Hospital,Bengbu Medical College,Bengbu 233010,Anhui Province,China;Department of Nursing,Fuyang Cancer Hospital,Fuyang 236000,Anhui Province,China;Department of Cardiac Rehabilitation,Shanghai First Rehabilitation Hospital,Shanghai 200090,China;Department of Radiation Oncology,Anhui Chest Hospital,Hefei 230022,Anhui Province,China;Department of Anesthesiology,Chaohu Hospital,Anhui Medical University,Hefei 238000,Anhui Province,China
引用格式:
[1]Jing Hong;Xiao-wan Xu;Jing Yang;Jing Zheng;Shu-mei Dai;Ju Zhou;Qing-mei Zhang;Yi Ruan;Chang-quan Ling-.Knowledge about,attitude and acceptance towards,and predictors of intention to receive the COVID-19 vaccine among cancer patients in Eastern China:A cross-sectional survey)[J].结合医学学报(英文版),2022(01):34-44
A类:
denying,worrying
B类:
Knowledge,about,attitude,acceptance,towards,predictors,intention,receive,among,cancer,patients,Eastern,China,cross,sectional,survey,Objective,coronavirus,disease,pandemic,has,had,serious,over,world,Cancer,whose,immunity,often,compromised,faces,huge,challenge,Currently,some,vaccines,being,developed,applied,general,population,however,whether,should,remains,unknown,Our,study,aimed,explore,knowledge,Methods,was,conducted,from,June,17th,September,3rd,Patients,were,selected,using,convenience,sampling,method,self,report,questionnaire,assess,following,review,similar,studies,previously,published,scientific,literature,multivariate,logistic,regression,analysis,used,determine,associated,Results,total,enrolled,this,hesitancy,further,participants,taken,get,vaccinated,variables,including,demo,graphic,characteristics,clinical,status,significant,dif,ferences,between,Multivariate,indicated,that,parameters,alcohol,consumption,odds,ratio,confidence,interval,reference,Ref,drinkers,income,impacted,by,mild,moderate,severe,respectively,believing,safety,willingness,pay,unwilling,families,friends,do,not,contributors,While,such,retired,unemployed,undergoing,multiple,therapies,ongoing,treatment,might,deteriorate,prog,nosis,Conclusion,This,provided,preliminary,estimates,rates,factors,occupation,parts,It,recommended,individualized,vaccination,plans,meet,healthcare,needs
AB值:
0.42526
相似文献
Sex disparity of lung cancer risk in non-smokers: a multicenter population-based prospective study based on China National Lung Cancer Screening Program
Wu Zheng;Tan Fengwei;Yang Zhuoyu;Wang Fei;Cao Wei;Qin Chao;Dong Xuesi;Zheng Yadi;Luo Zilin;Zhao Liang;Yu Yiwen;Xu Yongjie;Ren Jiansong;Shi Jufang;Chen Hongda;Li Jiang;Tang Wei;Shen Sipeng;Wu Ning;Chen Wanqing;Li Ni;He Jie-Office of Cancer Screening, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China;Key Laboratory of Cancer Data Science, Chinese Academy of Medical Sciences, Beijing 100021, China;Department of Thoracic Surgery, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China;PET-CT Center, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China;Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu 211166, China;Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, Jiangsu 211166, China;Department of Diagnostic Radiology, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
A trial of arbidol hydrochloride in adults with COVID-19
Zhao Jingya;Zhang Jinnong;Jin Yang;Tang Zhouping;Hu Ke;Sun Hui;Shi Mengmeng;Yang Qingyuan;Gu Peiyu;Guo Hongrong;Li Qi;Zhang Haiying;Li Chenghong;Yang Ming;Xiong Nian;Dong Xuan;Xu Juanjuan;Lin Fan;Wang Tao;Yang Chao;Huang Bo;Zhang Jingyi;Chen Shi;He Qiong;Zhou Min;Qu Jieming-Department of Pulmonary and Critical Care Medicine, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200025, China;Institute of Respiratory Diseases, School of Medicine, Shanghai Jiao Tong University, Shanghai 200025, China;Department of Emergency, Union Medical College Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430058, China;Department of Respiratory and Critical Care Medicine, Union Medical College Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430058, China;Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, China;Department of Respiratory and Critical Care Medicine, Renmin Hospital, Wuhan University, Wuhan, Hubei 430060, China;Department of Endocrinology, Union Medical College Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430058, China;Department of Respiratory Medicine, Wuhan Bauhinia Hospital, Wuhan, Hubei 430062, China;Department of Respiratory Medicine, Guanggu Hospital District, The Third Hospital of Wuhan, Wuhan, Hubei 430074, China;Department of Respiratory and Critical Care Medicine, Puren Hospital, Wuhan University of Science and Technology, Wuhan, Hubei 430081, China;Department of Respiratory Medicine, The Third People’s Hospital of Hubei Province, Wuhan, Hubei 430030, China;Department of Respiratory Medicine, The Sixth General Hospital of Hubei Province, Wuhan, Hubei 430015, China;Tuberculosis Department of Chengdu Public Health Clinical Medical Center, Chengdu, Sichuan 610066, China;Department of Neurology, Wuhan Red Cross Hospital, Wuhan, Hubei 430015, China;Department of Tuberculosis, Jinyintan Hospital, Wuhan, Hubei 430048, China;Department of Cardiology, The Third People’s Hospital of Hubei Province, Wuhan, Hubei 430030, China
Epidemiological characteristics of pulmonary tuberculosis in patients with pneumoconiosis based on its social determinants and risk factors in China: a cross-sectional study from 27 provinces
Wang Huanqiang;Dai Huaping;He Jiayu;Lyu Xiangpei;Zhang Xinran;Li Tao-Department of Occupational Respiratory Disease, National Institute for Occupational Health and Poison Control, Chinese Center for Disease Control and Prevention, Beijing 100050, China;National Center for Respiratory Medicine, National Clinical Research Center for Respiratory Diseases, Institute of Respiratory Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100029, China;Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing 100029, China;Department of Clinical Research and Data Management, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing 100029, China
Early assessment of the safety and immunogenicity of a third dose(booster)of COVID-19 immunization in Chinese adults
Yuntao Zhang;Yunkai Yang;Niu Qiao;Xuewei Wang;Ling Ding;Xiujuan Zhu;Yu Liang;Zibo Han;Feng Liu;Xinxin Zhang;Xiaoming Yang-China National Biotec Group Company Limited,Beijing 100024,China;Shanghai Institute of Hematology,State Key Laboratory of Medical Genomics,National Research Center for Translational Medicine at Shanghai,Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine,Shanghai 200025,China;Beijing Institute of Biological Products,China National Biotec Group Company Limited,Beijing 100176,China;National Vaccine and Serum Institute,China National Biotec Group Company Limited,Beijing 101111,China;Department of Infectious Diseases,Research Laboratory of Clinical Virology,Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine,Shanghai 200025,China
Seroprevalence of influenza viruses in Shandong,Northern China during the COVID-19 pandemic
Chuansong Quan;Zhenjie Zhang;Guoyong Ding;Fengwei Sun;Hengxia Zhao;Qinghua Liu;Chuanmin Ma;Jing Wang;Liang Wang;Wenbo Zhao;Jinjie He;Yu Wang;Qian He;Michael J.Carr;Dayan Wang;Qiang Xiao;Weifeng Shi-Key Laboratory of Etiology and Epidemiology of Emerging Infectious Diseases in Universities of Shandong,Shandong First Medical University&Shandong Academy of Medical Sciences,Taian 271000,China;School of Public Health,Shandong First Medical University&Shandong Academy of Medical Sciences,Jinan 250117,China;The Department of Infectious Disease,The Second Affiliated Hospital of Shandong First Medical University,Taian 271000,China;Clinical Laboratory,The Department of Clinical Laboratory,Boshan District Hospital,Zibo 255200,China;Clinical Laboratory,The Department of Clinical Laboratory,The Second Affiliated Hospital of Shandong First Medical University,Taian 271000,China;The Department of Cancer Center,Taian Tumor Prevention and Treatment Hospital,Taian 271000,China;National Virus Reference Laboratory,School of Medicine,University College Dublin,Dublin 4,Ireland;International Collaboration Unit,International Institute for Zoonosis Control,Hokkaido University,Sapporo,Hokkaido,001-0020,Japan;Chinese National Influenza Center,National Institute for Viral Disease Control and Prevention,Collaboration Innovation Center for Diagnosis and Treatment of Infectious Diseases,Chinese Center for Disease Control and Prevention,Key Laboratory for Medical Virology,National Health and Family Planning Commission,Beijing 102206,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。